Articles Referencing KERX

Benzinga

Mid-Day Market Update: CARBO Ceramics Rising, Keyx Continues to Give Back Gains

Mid-way through trading Friday, the Dow traded up 0.85 percent to 13,995.24 while the NASDAQ rose 1.20 percent to 3,179.75. The S&P also rose, increasing 0.99 percent to 1,512.54. Top... Read >>

Benzinga

Market Wrap for Tuesday, January 29: Dow and S&P Record Solid Gains, Nasdaq Lags

The U.S. stock market closed Tuesday's trading session mixed with the Dow and S&P recording solid gains and the Nasdaq finishing close to unchanged. Despite a steep decline in consumer... Read >>

SeekingAlpha

Neuralstem Is Speculative, But Its Work In Stem Cell Therapy Can't Be Ignored

By Smith On Stocks : Introduction I think that the potential of stem cell therapy has captured the imagination of most biotechnology investors who see it as a new potential driver for the... Read >>

Louis Navellier

7 Biotech Penny Stocks to Buy

3 Breakout Stocks Under $5 Biotech stocks are on the rise right now for many reasons. I recently wrote about the coming shift out of bonds and into... Read >>

SeekingAlpha

Curtain Closes on ASCO: 2010's Few Winners

The Burrill Report submits: By Peter Winter In previous years, shares in biotech and pharmaceutical companies have routinely jumped on the release of positive research results at... Read >>

SeekingAlpha

AEterna Zentaris: Uncovering Next Dominant Cancer Company

The oncology-focused companies, led by Dendreon ( DNDN ) and Human Genome ( HGSI ), have become the biotechnology and drugs sectors' hottest new fad, stealing the spotlight and making... Read >>

SeekingAlpha

13 Biotechs to Watch for at Hematology Conference

Michael Becker submits: The 51st American Society of Hematology [ASH] Annual Meeting will take place December 5-8, 2009, at the Ernest N. Morial Convention Center in New Orleans, LA. This... Read >>

SeekingAlpha

Four Biotech Stocks to Play the Sector Pullback

VFC submits: When an entire sector - or the broad market as a whole - decides to take a dip, that's when I like to go on a buying spree and as investors of the biotech/small pharma sector... Read >>